Quantcast

Using cells from mice, scientists from Iowa and Iran have discovered a new strategy for making embryonic stem cell transplants less likely to be rejected by a recipient’s immune system. This strategy, described in a new research report appearing in the February 2010 print issue of The FASEB Journal (http://www.fasebj.org), involves fusing bone marrow cells to embryonic stem cells. Once fused, the hybrid cells have DNA from both the donor and recipient, raising hopes that immune rejection of embryonic stem cell therapies can be avoided without drugs.

Leave a Reply

Your email address will not be published. Required fields are marked *

*